• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Divi's Laboratories Ltd

+ Add to Watchlist

DIVI:IN

1,475.00 INR 10.40 0.71%

As of 04:22:47 ET on 07/10/2014.

Snapshot for Divi's Laboratories Ltd (DIVI)

Open: 1,450.55 Day's Range: 1,403.00 - 1,498.55 Volume: 213,353
Previous Close: 1,464.60 52wk Range: 905.00 - 1,549.10 1-Yr Rtn: +49.91%

Stock Chart for DIVI

No chart data available.
  • DIVI:IN 1,477.60
  • 1D
  • 1M
  • 1Y
1,464.60
Interactive DIVI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DIVI

Current P/E Ratio (ttm) 24.5280
Estimated P/E(03/2015) 20.8771
Relative P/E vs. SENSEX 1.4664
Earnings Per Share (INR) (ttm) 58.2600
Est. EPS (INR) (03/2015) 68.4960
Est. PEG Ratio 1.6059
Market Cap (M INR) 189,677.30
Shares Outstanding (M) 132.73
30 Day Average Volume 259,240
Price/Book (mrq) 6.6569
Price/Sale (ttm) 7.8115
Dividend Indicated Gross Yield 1.40%
Cash Dividend (INR) 20.0000
Dividend Ex-Date
5 Year Dividend Growth 37.97%
Next Earnings Announcement 05/22/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DIVI

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for DIVI

Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.

Murali Krishna Prasad DiviChairman/Managing DirectorL Kishore BabuChief Financial Officer
Ramesh Babu LChief Information OfficerSrinivasa Rao PChief Technologist
More Company Profile & Key Executives for DIVI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil